Atlas Logo
TrackOn-HD
BACK
Sample details

TrackOn-HD was designed to investigate changes from health to early stage 2 of Huntington's disease (HD) using a wide range of measurements. Pre-HD and age- and sex-matched control participants were largely recruited from the existing Track-HD study, which was a precursor to TrackOn-HD. Early HD participants were recruited from university medical centres in England, France, Canada, and the Netherlands. At each centre, the study recruited participants between the ages of 18 and 65, unless they had previously participated in the Track-HD study. This resulted in a baseline cohort of 239 participants.

Study design
Cohort

Number of participants at first data collection

239 (participants)

Age at first data collection

18 - 65 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Multi-site
Dataset details
Loading map...

Countries

Canada, France, Netherlands, United Kingdom of Great Britain and Northern Ireland

Year of first data collection

2012

Primary Institutions

Leiden University Medical Center (Leids Universitair Medisch Centrum, LUMC)

Pierre and Marie Curie University (Université Pierre-et-Marie-Curie, UPMC)

University College London (UCL)

University of British Columbia (UBC)

Links

neurodegenerationresearch.eu/cohort/track-hd-and-trackon-hd/

portal.dementiasplatform.uk/CohortDirectory/Item

Funders

CHDI Foundation

Medical Research Council (MRC)

National Institute for Health and Care Research (NIHR)

Wellcome Trust

Ongoing?
No

Data types collected

neuroImagingData
mentalHealthData
Quantitative data collection
  • Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
Qualitative data collection
  • None
Neuroimaging data collection
  • Diffusion Tensor Imaging (DTI)
  • Functional magnetic resonance imaging (fMRI)
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
Linked or secondary data
  • None
Features

Engagement

  • None
  • Keywords

    Biological samples/biospecimens
    Biomarkers
    Genetic predisposition
    Huntington's Disease (HD)
    Neurodegeneration
    Neuroimaging

    Consortia and dataset groups

    Track HD Cohorts
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis